What is refeeding syndrome?

What is Refeeding Syndrome

Refeeding syndrome is a potentially fatal metabolic disorder characterized by severe electrolyte shifts—particularly hypophosphatemia, hypokalemia, and hypomagnesemia—that occurs when nutrition is reintroduced to severely malnourished patients, leading to cardiac arrhythmias, respiratory failure, neurological dysfunction, and death if not prevented. 1

Pathophysiology

The syndrome develops through a specific metabolic cascade that occurs when the body transitions from starvation to a fed state:

During starvation, the body adapts by down-regulating cellular membrane pumping to conserve energy. This causes intracellular electrolytes (potassium, magnesium, calcium, and phosphate) to leak out of cells, creating whole-body depletion despite potentially normal serum levels. Simultaneously, sodium and water shift into cells. 2

Upon refeeding, this process reverses abruptly. The sudden influx of glucose stimulates insulin release, which drives phosphate, potassium, and magnesium rapidly back into cells for anabolic processes. This creates precipitous drops in circulating electrolyte levels. The malnourished kidneys cannot adequately excrete the salt and water load from feeding, leading to fluid overload and extracellular volume expansion. 2

Clinical Manifestations

The syndrome typically manifests within 2-5 days of initiating nutrition support 3, 4, though it can occur within the first 4 days 5. The severity ranges from asymptomatic biochemical abnormalities to life-threatening organ failure:

Cardiovascular complications (most fatal):

• Cardiac arrhythmias and sudden cardiac arrest
• Congestive heart failure
• Impaired myocardial contractility from electrolyte-depleted energy metabolism 6

Neurological manifestations:

• Delirium and confusion
• Encephalopathy
• Coma
• Wernicke-Korsakoff syndrome from thiamine deficiency 2, 5

Respiratory complications:

• Respiratory failure from diaphragmatic weakness 2

Metabolic derangements:

• Hypophosphatemia (hallmark finding)
• Hypokalemia
• Hypomagnesemia
• Hypocalcemia
• Fluid retention with peripheral edema
• Disturbed glucose homeostasis
• Hyperlactatemia 1, 5

High-Risk Populations

Risk stratification is essential. Patients at highest risk include those with 5:

Very high risk (one or more):

• BMI <16 kg/m²
• Unintentional weight loss >15% in 3-6 months
• Little or no nutritional intake for >10 days
• Pre-existing low potassium, phosphate, or magnesium

High risk (two or more):

• BMI <18.5 kg/m²
• Unintentional weight loss >10% in 3-6 months
• Little or no intake for >5 days
• History of chronic alcoholism
• Chronic drug use (insulin, antacids, diuretics)

Additional vulnerable groups:

• Anorexia nervosa patients
• Critically ill and elderly patients
• Post-bariatric surgery patients
• Patients with chronic malnutrition 6, 3

Prevention Strategies (Critical)

Prevention is the cornerstone of management and dramatically reduces morbidity and mortality when protocols are followed 6, 4. The approach must be aggressive and systematic:

Initial feeding rates:

• Very high-risk patients: Start at 5-10 kcal/kg/day, increasing slowly over 4-7 days 1
• High-risk patients: Start at no more than 10-20 kcal/kg/day 6
• Some authorities suggest even 20 kcal/kg/day may be too aggressive 2

Critical caveat: The traditional approach of correcting electrolytes before feeding provides false security. Severely malnourished patients may have intracellular deficits totaling hundreds of mmol that cannot be corrected without simultaneous feeding to drive transmembrane transfer. Therefore, provide generous electrolyte supplementation with feeding at 10 kcal/kg/day rather than before. 2

Electrolyte supplementation requirements:

• Potassium: 2-4 mmol/kg/day
• Phosphate: 0.3-0.6 mmol/kg/day
• Magnesium: 0.2 mmol/kg/day IV or 0.4 mmol/kg/day orally 1

Thiamine supplementation (often overlooked):

Thiamine must be given intravenously at 200-300 mg daily, starting before feeding begins and continuing for at least the first 3 days. 2 This prevents Wernicke encephalopathy and cardiac dysfunction.

Implementation gap alert: Despite clear guidelines, thiamine prophylaxis reaches only 11% of severe-risk patients in practice, representing a critical failure point. 7

Monitoring protocol:

• Close monitoring of potassium, magnesium, calcium, and phosphate levels
• Volume status, fluid balance, heart rate and rhythm
• Clinical status assessment
• Monitor for at least the first 5 days of nutritional support 5, 4

Diagnostic Criteria

The 2020 ASPEN definition provides standardization 3:

• Fluid imbalance with edema
• Disturbed glucose homeostasis
• Hyperlactatemia (suggesting thiamine deficiency)
• Hypophosphatemia (most frequent and characteristic)
• Hypomagnesemia
• Hypokalemia

Occurring within the first 5 days of initiating nutrition support in at-risk patients.

Incidence and Recognition Challenges

Reported incidence varies widely from 0% to 62% depending on population and diagnostic criteria used 6. In pediatric populations, approximately 10% of at-risk patients develop the syndrome 7. The condition remains significantly underdiagnosed due to nonspecific clinical presentation, inconsistent definitions, and inadequate clinical awareness among medical and nursing staff 3, 4.

Route of Nutrition

Refeeding syndrome can occur with any form of nutritional support—oral, enteral, or parenteral 1. The route does not prevent the syndrome; only gradual caloric advancement with electrolyte supplementation does.